Tci Wealth Advisors, Inc. Alkermes Plc. Transaction History

Tci Wealth Advisors, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$25.31 - $29.02 $11,794 - $13,523	466 Added 105.43%	908 $25,000
Q4 2022 Feb 06, 2023	SELL	$21.94 - $26.24 $9,368 - $11,204	-427 Reduced 49.14%	442 $11,000
Q3 2022 Nov 08, 2022	BUY	$22.0 - $31.87 $8,140 - $11,791	370 Added 74.15%	869 $19,000
Q1 2022 Apr 29, 2022	BUY	$23.07 - $27.99 $7,566 - $9,180	328 Added 191.81%	499 $13,000
Q4 2021 Jan 24, 2022	SELL	$21.47 - $32.08 $50,883 - $76,029	-2,370 Reduced 93.27%	171 $4,000
Q3 2021 Oct 29, 2021	BUY	$23.37 - $32.13 $49,918 - $68,629	2,136 Added 527.41%	2,541 $78,000
Q2 2021 Aug 02, 2021	BUY	$18.78 - $25.15 $4,394 - $5,885	234 Added 136.84%	405 $10,000
Q4 2020 Jan 21, 2021	BUY	$15.39 - $22.1 $2,631 - $3,779	171 New	171 $3,000
Q2 2020 Jul 20, 2020	SELL	$13.31 - $19.41 $33,275 - $48,525	-2,500 Closed	0 $0
Q1 2020 Apr 14, 2020	BUY	$13.06 - $21.24 $6,530 - $10,620	500 Added 25.0%	2,500 $36,000
Q4 2019 Jan 27, 2020	BUY	$17.29 - $21.74 $34,580 - $43,480	2,000 New	2,000 $41,000

362

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.9B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.